✦ LIBER ✦

Expression of MTA2 gene in ovarian epithelial cancer and its clinical implication

✍ Scribed by Ji Yuxin; Zhang Ping; Lu Yunping; Ma Ding

Publisher: Springer-Verlag
Year: 2006
Tongue: Chinese
Weight: 708 KB
Volume: 26
Category: Article
ISSN: 0510-9752
DOI: 10.1007/bf02829576

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

mRNA expression of PTEN and VEGF genes i

mRNA expression of PTEN and VEGF genes in epithelial ovarian cancer

✍ Ying Chen; Yu-jie Zhao; Hua-chuan Zheng; Xue-fei Yang; Gui-lan Wang; Yan Xin 📂 Article 📅 2003 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 522 KB

Clinical implication of serum sIL-2R lev

Clinical implication of serum sIL-2R levels in ovarian cancer

✍ Shixuan, Wang ;Guiru, Cai ;Yunping, Lu 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 246 KB

Clinical implication of CD166 expression

Clinical implication of CD166 expression in gastric cancer

✍ Sumiya Ishigami; Shinichi Ueno; Takaaki Arigami; Hideo Arima; Yasuto Uchikado; Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Prevalence and significance of HER-2/neu

Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer

✍ Stephen C. Rubin; Connie L. Finstad; Mark G. Federici; Linda Scheiner; Kenneth O 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Increased expression of the nme1 gene is

Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer

✍ Jennifer A. Leary; Judith Kerr; Georgia Chenevix-Trench; Claire P. Doris; Terry 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 973 KB

A subset of these data has been published-Dl7S5 (47 patients) and D17S74 (40 patients) (Leary et al., 1993).

RASSF1A gene inactivation in non-small c

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication

✍ Hideki Endoh; Yasushi Yatabe; Shigeki Shimizu; Kohei Tajima; Hiroyuki Kuwano; Ta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 227 KB 👁 1 views

## Abstract Methylation‐associated inactivation of __RASSF1__, a putative tumor suppressor identified at 3p21.3, is reported in several cancers. We examined __RASSF1__ in non‐small lung cancer (NSCLC) to search for clinical implications. RT‐PCR analysis showed no expression of __RASSF1A__ in 12 of